IDx20 combines rapid and highly accurate test results, affordability, ease of use, and real-time monitoring and data sharing.

The lab-made reagents they utilize come from immune cells (B cells) of mammals exposed to the disease. And from humans or animal reservoirs early in the epidemic cycle.

They use these novel recombinant molecules with high detection performance to pathogens.